| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Antibiotics (Resistance)ESBLPseudomonas aeruginosaCarbapenemasePlasmid| 1 | 1992 | Active efflux mechanisms for antimicrobial resistance. | 
| + | - | nl | Antimicrob Agents Chemother 36(4):695-703 (1992) |
| 2 | 2007 | Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. |
| + | - | nl | J Antimicrob Chemother 59(6):1237-46 (2007) |
| 3 | 2007 | Bacterial efflux pump inhibitors from natural sources. |
| + | - | nl | J Antimicrob Chemother 59(6):1247-60 (2007) |
| 4 | 2007 | Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection? |
| + | - | nl | J Antimicrob Chemother 59(6):1230-6 (2007) |
| 5 | 2005 | Efflux-mediated antimicrobial resistance. |
| + | - | nl | J Antimicrob Chemother 56(1):20-51 (2005) |
| 6 | 2003 | Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. |
| + | - | nl | J Antimicrob Chemother 51(5):1055-65 (2003) |
| 7 | 2003 | Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics. |
| + | - | nl | J Antimicrob Chemother 51(5):1067-77 (2003) |
| 8 | 2003 | The importance of efflux pumps in bacterial antibiotic resistance. |
| + | - | nl | J Antimicrob Chemother 51(1):9-11 (2003) |
| 9 | 1996 | The Garrod Lecture. Evasion of antibiotic action by bacteria. |
| + | - | nl | J Antimicrob Chemother 37(5):855-69 (1996) |
| 10 | 2000 | Molecular properties of bacterial multidrug transporters. |
| + | - | nl | Microbiol Mol Biol Rev 64(4):672-93 (2000) |
| 11 | 2008 | Evolving problems with resistant pathogens. |
| + | - | nl | Clin Microbiol Infect 14 Suppl 3(-):3-14 (2008) |
| 12 | 2007 | The emergence of antibiotic resistance by mutation. |
| + | - | nl | Clin Microbiol Infect 13(1):5-18 (2007) |
| 13 | 2001 | Emerging mechanisms of fluoroquinolone resistance. |
| + | - | nl | Emerg Infect Dis 7(2):337-41 (2001) |
| 14 | 1992 | Antibiotic resistance in bacteria. |
| + | - | nl | J Med Microbiol 36(1):4-29 (1992) |
| 15 | 1990 | Trimethoprim resistance; epidemiology and molecular aspects. |
| + | - | nl | J Med Microbiol 31(1):1-19 (1990) |
| 16 | 2011 | Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. |
| + | - | nl | Mayo Clin Proc 86(3):250-9 (2011) |
| 17 | 2002 | Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. |
| + | - | nl | Clin Infect Dis 34(4):482-92 (2002) |
| 18 | 2008 | Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. | 
| + | - | nl | Br J Pharmacol 153 Suppl 1(-):S347-57 (2008) |
| 19 | 2010 | Mobile genetic elements of Staphylococcus aureus. |
| + | - | nl | Cell Mol Life Sci 67(18):3057-71 (2010) |
| 20 | 2003 | Antimicrobial resistance: the example of Staphylococcus aureus. |
| + | - | nl | J Clin Invest 111(9):1265-73 (2003) |
| 21 | 2009 | Role of reactive oxygen species in antibiotic action and resistance. |
| + | - | nl | Curr Opin Microbiol 12(5):482-9 (2009) |
| 22 | 2009 | Efflux-mediated antifungal drug resistance. |
| + | - | nl | Clin Microbiol Rev 22(2):291-321, Table of Contents (2009) |
| 23 | 2010 | Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. |
| + | - | nl | Crit Care 14(1):R20 (2010) |
| 24 | 2011 | Emerging resistance in Gram-negative pathogens and implications for clinical practice. | 
| + | - | nl | Future Microbiol 6(1):19-22 (2011) |
| 25 | 2011 | Antibacterial resistance: is there a way out of the woods? |
| + | - | nl | Future Microbiol 6(7):707-9 (2011) |
| 26 | 2011 | Developments in antimicrobial resistance and treatment. |
| + | - | nl | Future Microbiol 6(7):715-20 (2011) |
| 27 | 2009 | Multicomponent drug efflux complexes: architecture and mechanism of assembly. |
| + | - | nl | Future Microbiol 4(7):919-32 (2009) |
